Cargando…
Targeted deep sequencing improves outcome stratification in chronic myelomonocytic leukemia with low risk cytogenetic features
Clonal cytogenetic abnormalities are found in 20-30% of patients with chronic myelomonocytic leukemia (CMML), while gene mutations are present in >90% of cases. Patients with low risk cytogenetic features account for 80% of CMML cases and often fall into the low risk categories of CMML prognostic...
Autores principales: | Palomo, Laura, Garcia, Olga, Arnan, Montse, Xicoy, Blanca, Fuster, Francisco, Cabezón, Marta, Coll, Rosa, Ademà, Vera, Grau, Javier, Jiménez, Maria-José, Pomares, Helena, Marcé, Sílvia, Mallo, Mar, Millá, Fuensanta, Alonso, Esther, Sureda, Anna, Gallardo, David, Feliu, Evarist, Ribera, Josep-Maria, Solé, Francesc, Zamora, Lurdes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302970/ https://www.ncbi.nlm.nih.gov/pubmed/27486981 http://dx.doi.org/10.18632/oncotarget.10937 |
Ejemplares similares
-
Analysis of Intratumoral Heterogeneity in Myelodysplastic Syndromes with Isolated del(5q) Using a Single Cell Approach
por: Acha, Pamela, et al.
Publicado: (2021) -
Impact of mutational studies on the diagnosis and the outcome of high-risk myelodysplastic syndromes and secondary acute myeloid leukemia patients treated with 5-azacytidine
por: Cabezón, Marta, et al.
Publicado: (2018) -
Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia
por: Patnaik, M M, et al.
Publicado: (2016) -
Spanish Guidelines for the use of targeted deep sequencing in myelodysplastic syndromes and chronic myelomonocytic leukaemia
por: Palomo, Laura, et al.
Publicado: (2019) -
Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcome
por: Patnaik, M M, et al.
Publicado: (2015)